LIFECORE BIOMEDICAL, INC. Operating Leases, Future Minimum Payments, Due in Four Years
LIFECORE BIOMEDICAL, INC. (LFCR) had Operating Leases, Future Minimum Payments, Due in Four Years of $3.35 million as of 2019-05-26, per its 10-K filed 2020-08-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-08-14
- 2019-05-26: Operating Leases, Future Minimum Payments, Due in Four Years $3.35M.
- 2018-05-27: Operating Leases, Future Minimum Payments, Due in Four Years $1.84M.
- 2017-05-28: Operating Leases, Future Minimum Payments, Due in Four Years $1.14M.
- 2016-05-29: Operating Leases, Future Minimum Payments, Due in Four Years $612.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2019-05-26 | $3.35M 10-K · filed 2020-08-14 |
| 2018-05-27 | $1.84M 10-K · filed 2018-08-09 |
| 2017-05-28 | $1.14M 10-K/A · filed 2018-03-15 |
| 2016-05-29 | $612.00K 10-K · filed 2016-08-01 |
| 2015-05-31 | $1.00M 10-K · filed 2015-07-31 |
| 2014-05-25 | $1.38M 10-K · filed 2014-08-01 |
| 2013-05-26 | $1.14M 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |